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Abstract: Osteochondral defects are a common problem in both human medicine and veterinary
practice although with important limits concerning the cartilaginous tissue regeneration. Interest in
the subchondral bone has grown, as it is now considered a key element in the osteochondral defect
healing. The aim of this work was to generate and to evaluate the architecture of three cell-free
scaffolds made of collagen, magnesium/hydroxyapatite and collagen hydroxyapatite/wollastonite
to be implanted in a sheep animal model. Scaffolds were designed in a bilayer configuration and a
novel “Honey” configuration, where columns of hydroxyapatite were inserted within the collagen
matrix. The use of different types of scaffolds allowed us to identify the best scaffold in terms of
integration and tissue regeneration. The animals included were divided into four groups: three were
treated using different types of scaffold while one was left untreated and represented the control
group. Evaluations were made at 3 months through CT analysis. The novel “Honey” configuration
of the scaffold with hydroxyapatite seems to allow for a better reparative process, although we are
still far from obtaining a complete restoration of the defect at this time point of follow-up.
Keywords: osteochondral defects; scaffold; biomaterials
1. Introduction
Articular cartilage and subchondral bone form a well-integrated system, with unique
biomechanical properties, that provides the efficient transmission of significant static and dynamic
loads [1,2]. This osteochondral tissue may frequently undergo damage by trauma and disease; as a
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consequence, the joint undergoes an osteoarthritic degeneration leading to severe pain, joint deformity,
and loss of joint motion [3–7]. The degeneration may initiate at different locations. It could start from
the subchondral bone, which becomes weaker and unable to support a proper loading, causing a
consequent cartilage degeneration [8–10]. On the other hand, the lesion may begin on the cartilage
tissue, therefore inducing altered stimulus to the subchondral bone, which becomes sclerotic [9]. Both
scenarios may be responsible for modifying the performance of the osteochondral structure. The
osteochondral tissue has a poor spontaneous regenerative potential, due to the scarce presence of
multipotent cells in cartilage and due to the insufficient migration of cells from the bone marrow; thus,
when damaged, it repairs with a tissue characterized by low biomechanical and biological properties.
Its treatment represents a major challenge in the human and veterinary orthopedic field and has driven
different lines of research, both in vitro and in orthotopic models [11–16]. In the clinical practice, several
solutions have been proposed for osteochondral repair: the most common techniques are based on the
recruitment of multipotent cells from the bone marrow [11,17]. However, the repairing tissue is mainly
fibro-cartilaginous and does not exhibit the mechanical properties of native hyaline cartilage [17].
Osteochondral transplantation has been widely used as autologous tissue and as allograft [18–23].
However, in recent years regenerative medicine is taking advantages not only of traditional implants,
but also of engineered biocompatible parts, including degradable porous scaffolds in some cases
integrated with cells or molecules. Indeed, several scaffolds have been developed for osteochondral
lesions [23] combining cell-free strategies and the use of different layers to mimic the bone-cartilage
structure [12,24–27]. It is worth noting that bone and osteochondral scaffold design must enable
hierarchical composites porous structures to attain desired mechanical function and mass transport,
and to produce these structures within arbitrary and complex three-dimensional (3D) anatomical
shake [27]. Our paper attempts to give a contribute in this field, proposing new osteochondral scaffold
configurations and assessing their in vivo behavior.
Particularly, the aim of this study was to evaluate, at three months follow up, the regenerative
performances of three cell-free scaffolds in collagen and Mg doped hydroxyapatite or in collagen
and hydroxyapatite/wollastonite in a sheep model. In our study, two different three-dimensional
collagen/HA osteochondral substitutes were proposed. In the first configuration, called “Bi-layer”,
a highly porous ceramic scaffold was surrounded in circumference by a thin layer of collagen,
and characterized by a stable pre-integration between the osteo (ceramic) and chondral (collagen)
components, easily surgically handled, and compliant at the implant site. In the second configuration,
called “Honey”, highly porous columns of hydroxyapatite were inserted within the cylindrical collagen
scaffold. The preparation of these different scaffolds is presented in this paper and the preliminary
results following their implantation in a sheep model were also reported.
2. Materials and Methods
2.1. Scaffold Design and Realization
The inorganic component, both for the Bi-layer and for the Honey configurations, was synthesized
with the foam replication method [28–35] and composed of Mg doped hydroxyapatite (Mg-HA,
HMG group) or wollastonite/hydroxyapatite (WS/HA, HWS group) mixtures. Mg-HA was prepared
replacing a 10% molar of calcium ions, keeping the (Ca + Mg)/P = 1.67. WS/HA scaffold was prepared
by sintering WS/HA mixtures powders in a 1/1 ratio. The Bi-layer scaffolds were then produced
accordingly to the procedure previously reported [36] and the bioceramic pillars were embedded in
the collagen type I layer [37,38] to form the biphasic Honey scaffolds [39]. The organic component,
made of collagen, was fabricated by freeze-drying a collagen solution (2% wt/v) following a previously
reported protocol [32,33]. All biphasic substitutes were sterilized in oven under vacuum at 160 ◦C for
2–4 h before implantation. All configurations tested, with corresponding sample names and materials
used to produce the scaffold (both cartilage and bone substitute) are reported in Table 1.
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Table 1. Design of osteochondral scaffold used in the in vivo study. For each configuration tested,
sample names and the materials used to produce the scaffold (both cartilage and bone substitute)
are reported.
Osteochondral Scaffold Sketch Osteochondral Scaffold
Configuration
Sample
Name
Scaffold Material
Top View Side View Cartilage Scaffold Bone Scaffold
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After the approval of the Italian Ministry of Health and in strict accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals (D.L. 26/2014) of the 
National Institutes of Health, the sheep selected for the experimental treatment were identified and 
stabled for 30 days for acclimatization. 
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Bilayer BWS Collagen Blend WS/HA
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Bi-lay r and Honey scaffolds have been characterized in terms of (i) ceramic p ase composition
by X Ray Diffraction (XRD); (ii) morphology by scanning electro icroscopy (SEM Zeiss Evo40, Jena,
Germany) and micro CT analysis; and (iii) mechanical resistance by uniaxial compression test.
The XRD pattern was registered with a D-Max/Ultima diffractometer (Rigaku, Tokyo, Japan) using
CuKa radiation (λ = 1.5418A◦) in the step scanning mode recorded in the 2θ range of 20–60◦, with a
step size of 0.02◦ and step duration of 0.5 s.
All the tomographic acquisitions were performed by a GE Phoenix Nanotom CT system equipped
with a 180 kV/15 W nanofocus X-ray tube and a 2300× 2300 pixel on 12 bit Hamamatsu flat panel detector.
A molybdenum target, suitable for weak absorbing specimens, was used for all the analyzed specimens.
The experimental conditions for the acquisition are summarized in Table 2. The volume reconstruction
was carried out with the proprietary application software Phoenix datos|x 2 reconstruction. The 3D
visualization and analysis software Avizo 8 Fire Edition of Visualization Sciences Group (a company
belonging to the FEI group) were used for the image processing of the datasets.
Table 2. Experimental conditions for the tomographic acquisition.
Voltage (kV) Current (µA) Voxel Size (µm3)
Exposure Time
(s) Projections
Scan Time
(min)
65 145 12.5 × 12.5 × 12.5 1.250 1400 176
The compression tests were performed using a mechanical analyzer (Lloyd LR5K instrument,
AMETEK Test & Calibration Instruments, Bognor Regis, UK) and five samples, both Bi-layer and
Honey, compressed at a crosshead speed of 0.5 mm/min and the maximum stress calculated. For each
experimental group, means were assessed by descriptive statistics. Each experimental group was
compared with the control group (CTRL) and standard Student’s t-test was performed. Statistical
significance was defined as a p-value of <0.05.
After the approval of the Italian Ministry of Health and in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory Animals (D.L. 26/2014) of the
National Institutes of Health, the sheep selected for the experimental treatment were identified and
stabled for 30 days for acclimatization.
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2.2. Management of the Animals and Surgical Procedures
All surgeries were performed by the same team under aseptic conditions and both general and
spinal anesthesia was made to minimize pain and suffering. Eighteen sheep, Bergamasca breed,
female 50 ± 4 Kg, 6 years old, were recruited and fasted for 24 h, then an intravenous catheter was
placed in the jugular vein. The sheep were sedated with ± midazolam (MIDAZOLAM 5 mg/mL
IBI, Aprilia, Italy, 0.4 mg/kg IV) and they were also treated with flunixin meglumine (FLUNIXIN 50
mg/mL, Norbrook, Agri Laboratories, UK, 1 mg/kg IV). When the desired sedation was reached, the
animals were placed on the right lateral decubitus to receive spinal anesthesia. The lombo-sacral
area was surgically scrubbed and the spinal anesthesia was performed through a subarachnoideal
injection using lidocaine (LIDOCAINA 2%, Esteve Veterinaria SPA, Italy, 2 mg/kg) and buprenorphine
(BUPRENODALE 0.3 mg/mL, Dechra, Italy, 300 mcg); during the procedure the sheep received oxygen
through a nasal catheter and eventually also a bolus of propofol (PROPOFOL 1%, Fresenius Kabi,
Germany, 1 mg/kg IV) was administered. During the surgery, sheep received fluids to a mean speed of
10 mg/kg/h adapting it to the condition of the patient. Then, sheep were placed in dorsal recumbence
with the right knee in flexion. The skin in the area was trimmed and scrubbed. After the disposition of
surgical drapes, a longitudinal incision of about 5–7 cm was made on the medial aspect of the right
knee, in the projection zone of the medial condyles. A capsulotomy and a partial removal of the Hoffa
body were performed to obtain a better exposition of the condyle. Subsequently, with a hyperflexion
of the knee to better expose the right medial condyle, an osteochondral lesion (11 mm of diameter
and 9 mm in depth) was generated on the load bearing part of the condyle, measuring with custom
made instruments (Core Punch, Sleeve, Hand drill). The lesion was neat and surrounded by healthy
cartilage. The scaffolds were inserted by press fit (Figure 1).Vet. Sci. 2019, 6 2 
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Figure 1. Osteochondral lesion practiced with custom made instruments. (A) Core millimeter punch
before its application. (B) Core millimeter punch inserted to a depth of 9 mm. (C) Hand drill inserted
in the sleeve. (D) Scaffold inserted with press-fit technique. (E) Scaffold implanted in situ.
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The joint capsule and the subcutaneous tissue were closed with absorbable sutures and the skin
was closed with non-absorbable sutures. A waterproof medication was placed on the lesions; the
animals were free to move without any bandage or immobilization tool. Postoperative X-ray were
practiced in all treated animals to evaluate the position of the scaffolds. All operated animals received
Benzylpenicillin procaine (IZOTRICILLINA 100 mL, IZO SRL, Italy, 10 mL of a 200,000 UI/mL solution
IV) and flunixin (FLUNIXIN 50 mg/mL, Norbrook, Agri Laboratories, UK, 1 mg/kg IV) every 24 h for
seven days.
The animals after the surgery were stabled in the Section of Veterinary Clinics and Animal
Production of the Department of Emergencies and Organ Transplantation (D.E.O.T.) of the University
of Bari. Every day during the experimental phase the animals were clinically controlled.
2.3. Protocol of the Study
The defects in three sheep were left untreated (CTRL), while the remaining 15 sheep were divided
into 3 groups: 5 lesions were treated with a biphasic scaffold made of collagen type I for the cartilaginous
phase and small cylinders of magnesium hydroxyapatite embedded in collagen type I for the osseous
component (HMG); 5 lesions were treated with a biphasic substitute formed by collagen type I and
wollastonite (BWS); 5 lesions were treated with a scaffold made of collagen type I and small cylinders of
wollastonite/hydroxyapatite embedded in collagen type I (HWS). We performed the power calculation
for a two-tailed t test with power of 0.95, an alpha error of 0.05 and an effect size of 0.86, using freely
available software (G*Power Version 3.0.10; University of Düsseldorf, Germany) [40]. The results of
this analysis suggested that a minimum of six sheep per group would be sufficient to detect significant
differences between groups.
All animals were euthanized after 3 months from surgery by 50 mL of a potassium chloride solution
administered IV after general anesthesia was induced with propofol (PROPOFOL 1%, Fresenius Kabi,
Germany) IV. Death of the animal was confirmed by the absence of heart beats by ECG monitoring and
absence of thoracic excursions.
For all animals, the treated leg was harvested without opening the knee joint, placed in a portable
refrigerator box and sent to Veterinary Medicine University of Milan in Lodi to undergo CT evaluation.
Subsequently, the tissues underwent gross analysis and histological examination [39].
2.4. CT Evaluation
The CT scans were performed on the harvested knees at the Department of Veterinary Medicine
(DIMEVET), Ospedale Didattico Universitario Az. Polo Veterinario di Lodi. In particular, for the CT
scans a GE BrightSpeed 16 slice CT machine was used. The acquisition protocol was performed as
follows: helical mode, slice thickness 1.25 mm, 120 kVp, 200 mA, pitch 0.93, convolution kernel “bone
plus”.
2.5. Macroscopic Evaluation
The skin and the articular capsule were opened, and macroscopic assessment of the knees was
performed by using the International Cartilage Repair Society (ICRS) Macroscopic Score, which
evaluates these specific parameters: leveling, stiffness, integration, degree of repair and overall
macroscopic aspect of the defects. Three different observers independently scored the samples [39].
3. Results
3.1. Pre-Implant Osteochondral Scaffolds Characterization
Two ceramic powders were synthesized to produce the “bone” scaffolds of the whole
substitutes implanted in the present study: namely, magnesium-doped hydroxyapatite (MG) and
hydroxyapatite/wollastonite composite (WS). In order to check if the desired material composition was
obtained, an X-ray diffraction analysis (XRD) was performed. The diffraction pattern of the synthesized
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ceramic powders confirmed the obtainment of the established MG and WS that are stable at high
sintering temperature (Figure 2). More in detail, MG underwent a slight dissociation in secondary
phases (mainly calcium oxide and magnesium phosphates), during the sintering processes, while WS
scaffolds could be fabricated and sintered without significant decomposition or phase changes with
respect to the starting materials.Vet. Sci. 2019, 6 4 
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The microCT analysis performed on the Honey configuration (Figure 4) allowed checking the
correct positioning of the ceramic pillars and the whole porous structure of the substitute.
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Figure 4. icro i ages of the hole oney scaffold (left) and of the cera ic pillars (right). Scale
ar 2 . (Please note that i ages are not rthogonal projections but are i ers ective a as a
c se e ce f it t e sc le r c i e l i ic ti e i f r ti ).
initial mechanical resistance of an osteochondral substitute i cr cial. However, the substitutes
proposed he e are not designed to bear the whole physi logical load, rather to off the proper
environment for cell c lonization and proliferati n. On the other hand, scaffold must sustain s rgical
handlings without any breaks. Mechanical tests in compressi n were hence p rformed to check the
stress at break of he two configurations, Bi-l yer and Honey, primarily to verify the mechanical
resist ce of the small ceramic pil ars and omp e them to the Bi-layer resistance. The average values
of maximum stress of Honey and Bi-layer scaffolds (n = 5) are rep rted i the histogram of Figure 5
(left). Honey scaffolds showed a higher average value of str ss at f ilure than Bi-layer; howev r, the
differ nce as not sign ficant, due to the high standard deviation. The stress–str in curve of both
Honey and Bi-layer scaffold configurations has the typical behavior of fragile materials, showing a
rapid and linear increase of stress as function of strain followed by a sudden break. Int restingly, in the
stress–strain curve of Honey scaffold, we distinguished four main peaks corresponding to the break of
the four small pillars embedded within the collagen matrix (Figure 5, right).
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3.2. In Vivo Results
All surgical procedures were performed without any major complication.
All animals treated were able to stand on their four legs and to bear the load on the operated limb
2–4 h after the surgery.
3.3. Radiological Evaluation
CT scans showed the persistence of the bony scaffold, well integrated with the surrounding bone
as shown in our previous publication [39] (Figure 6).
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Figure 6. CT evaluation of the three biphasic scaffolds. (a) Radiologic pictures of the experimental
groups; a representative lesion for each experimental group is shown. Control (CTRL): (a); HMG: (b);
HWS: (c); BWS: (d).
3.4. Macroscopic Evaluation
After performing the radiological evaluation, the sheep joints were dissected and macroscopically
evaluated with ICRS evaluation as previously shown [39]. The CTRL group was characterized by the
almost complete absence of reparative tissue, whereas the HMG lesion was partially filled with tissue.
Finally, the presence of wollastonite in the other two groups seemed to interfere negatively with the
reparative process (Figure 7).
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experimental samples was different, and it was characterized by a poor amount of reparative tissue.
4. Discussion
In this study, three kinds of cell-free biphasic scaffolds were analyzed as potential novel materials
for repairing osteochondral lesions. In previous studies from our group, an osteochondral substitute
seeded with st m cells [42] or a biphasic scaffold seeded with chondrocyte and a cell-free scaffold were
compared in a swine orthotopic model [30,36]. Surprisingly the s periorit of the unseeded scaffold
was evidenced in the short-term follow-up. Cell-free samples showed the presence of fewer cells, but
characterized by a chondrocyte-like phenotype. The osteochondral lesion repair in this model, though,
was far from complete. It was therefore decided to change the biphasic scaffold’s architecture in order
to improve the reparative potential and the integration of the substitute with the healthy tissue. Three
biphasic scaffolds with different designs and compositions were compared in this project: the aim was
to improve the scaffolds’ architecture to favor integration of the scaffold with healthy tissue and to
promote the acquisition of a chondrocyte phenotype of migrated cells. In particular, two different
scaffold configurations were designed and morphologically and mechanically characterized before
implantation. The SEM analysis performed on collagen and ceramic scaffolds showed that porosities
of both substitutes are highly interconnected and present an average pore size suitable for cartilage
and bone regeneration, respectively [29,37,38]. The mechanical properties in compression of the novel
configuration with four HA pillars embedded in the collagen matrix resulted comparable or even
higher of those of the Bi-layer configuration with a unique HA cylinder.
All biphasic scaffolds with different designs were successfully implanted on a sheep model
without any major adverse event. In this study, none of the groups showed a complete and successful
repair of the osteochondral lesion. However, the HMG configuration gave the best results in terms of
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integration and repair potential. The presence of wollastonite in the other two scaffolds may have
interfered with the healing process of the osteochondral lesion.
Moreover, our data successfully demonstrated the biocompatibility of all substitutes.
However, the experimental time (3 months) is not sufficient for a complete repair of an
osteochondral lesion. Thus, we are planning to analyze longer time points (6 months and 1 year).
Additionally, considering the shrinkage of some experimental samples, we also believe that these data
clearly suggested the need of coupling these materials with active molecules which may stimulate the
repair and regeneration of cartilaginous and bony tissues.
5. Conclusions
Highly interconnected three-dimensional collagen/hydroxyapatite scaffolds were manufactured
by replica method using a polyurethane sponge. They showed mechanical properties superior to those
reported in literature, demonstrating the efficacy of their sintering. Collagen scaffolds were successfully
fabricated by a freeze-drying technique. The construct porosity could be properly regulated by varying
the design parameters. Cross-linking treatments can improve the mechanical properties of the collagen
scaffold. The integration of the hydroxyapatite and the collagen of the osteochondral substitute was
properly obtained. The sheep model in vivo study, designed to assess the effectiveness of the proposed
scaffolds for repairing osteochondral defects, demonstrated the biocompatibility of three biphasic
cell-free scaffolds in an osteochondral defect. The new “Honey” configuration of the scaffold with
hydroxyapatite enabled better reparative process, although a complete restoration of the defect is still
far from being achieved. A new study, designed with the employment of the HMG scaffold in smaller
lesions, could represent a future attempt for correcting the incomplete repair. In order to stimulate
the migration of endogenous reparative cells and favor the reparative process, the addition of active
molecules or growth factors will also be considered, thus demonstrating the potentials of this new
biphasic cell-free substitute for the repair of osteochondral defects.
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